Latest Asx News

Redivium Limited has successfully completed the formalities for listing a €25 million green bond, aimed at accelerating its sustainable battery recycling projects across Europe, including the UK, Czech Republic, and Romania.

Redivium Limited’s recent entitlement offer failed to meet the minimum subscription, leading to its cancellation and full refunds to investors. The company now pivots towards a green bond funding strategy to support its battery recycling ambitions.

Regis Resources has established a $300 million revolving credit facility, replacing its previous term loan to enhance financial flexibility and liquidity amid a strong banking syndicate backing.

ARGO Investments Limited has updated its dividend distribution announcement, confirming a fully franked ordinary dividend of AUD 0.17 per share for the half-year ending December 2024 and correcting previous details on its Bonus Security Plan pricing.

Maas Group Holdings has announced a fresh on-market share buyback of up to 10% of its issued capital, signaling strong confidence in its financial health and future prospects.

Mosaic Brands announces the closure of its remaining Rivers, Millers, and Noni B stores after failing to secure a sale, impacting over 1,500 employees and marking the end of its retail operations by April 2025.

5G Networks Limited has extended its on-market takeover offer for AuCyber Limited shares, prolonging the bid period to mid-February 2025. This move signals continued strategic interest amid a competitive acquisition landscape.

5G Networks Limited has automatically extended its takeover offer for AuCyber Limited after increasing its voting power to over 50%, signaling a decisive step toward full control.

Calix Limited has successfully closed its Share Purchase Plan, raising $2.1 million to complement a prior $20 million institutional placement, strengthening its balance sheet to advance key environmental technology projects.

Biotron Limited reported a robust net cash inflow of $1.095 million for the December 2024 quarter, driven largely by government grants, supporting its operational stability despite ongoing R&D expenses.

Medlab Clinical reports a near-empty cash balance and zero receipts in Q2 2025, while actively pursuing a business acquisition ahead of its ASX removal date.

OM Holdings Limited has reported a strong finish to FY24 with production volumes surpassing guidance and outlined robust production targets for FY25 amid shifting market dynamics in ferrosilicon and manganese.